PT992501E - Derivados de acido piridonacarboxilico como agentes antibacterianos - Google Patents

Derivados de acido piridonacarboxilico como agentes antibacterianos

Info

Publication number
PT992501E
PT992501E PT99124494T PT99124494T PT992501E PT 992501 E PT992501 E PT 992501E PT 99124494 T PT99124494 T PT 99124494T PT 99124494 T PT99124494 T PT 99124494T PT 992501 E PT992501 E PT 992501E
Authority
PT
Portugal
Prior art keywords
halo
pyridonacarboxylic
acid derivatives
antibacterial agents
opt
Prior art date
Application number
PT99124494T
Other languages
English (en)
Inventor
Yasuhiro Kuramoto
Hirotaka Amano
Akira Yazaki
Yoshiko Niino
Yoshihiro Ohshita
Yuzo Hirao
Norihiro Hayashi
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26498637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT992501(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of PT992501E publication Critical patent/PT992501E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
PT99124494T 1995-09-22 1996-09-20 Derivados de acido piridonacarboxilico como agentes antibacterianos PT992501E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26928095 1995-09-22
JP17846296 1996-06-19

Publications (1)

Publication Number Publication Date
PT992501E true PT992501E (pt) 2003-01-31

Family

ID=26498637

Family Applications (3)

Application Number Title Priority Date Filing Date
PT99124494T PT992501E (pt) 1995-09-22 1996-09-20 Derivados de acido piridonacarboxilico como agentes antibacterianos
PT99111114T PT952151E (pt) 1995-09-22 1996-09-20 Intermediarios para utilizacao na preparacao de novos derivados de acido piridonacarboxilico ou seus sais
PT96931264T PT911327E (pt) 1995-09-22 1996-09-20 Novos derivados do acido piridonocarboxilico ou seus sais e agente antibacteriano compreendendo os mesmos como o ingrediente activo

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT99111114T PT952151E (pt) 1995-09-22 1996-09-20 Intermediarios para utilizacao na preparacao de novos derivados de acido piridonacarboxilico ou seus sais
PT96931264T PT911327E (pt) 1995-09-22 1996-09-20 Novos derivados do acido piridonocarboxilico ou seus sais e agente antibacteriano compreendendo os mesmos como o ingrediente activo

Country Status (17)

Country Link
US (3) US5998436A (pt)
EP (3) EP0992501B1 (pt)
JP (3) JP3103380B2 (pt)
KR (2) KR100299430B1 (pt)
CN (3) CN1105715C (pt)
AT (3) ATE222906T1 (pt)
AU (1) AU721805B2 (pt)
BR (2) BR9612862B8 (pt)
CA (3) CA2290712C (pt)
DE (3) DE69628466T2 (pt)
DK (3) DK0911327T3 (pt)
ES (3) ES2200439T3 (pt)
HK (2) HK1016602A1 (pt)
HU (3) HUP9904390A3 (pt)
PT (3) PT992501E (pt)
RU (3) RU2177945C1 (pt)
WO (1) WO1997011068A1 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0594379U (ja) * 1992-05-11 1993-12-24 株式会社イナックス 便器洗浄水タンクの手洗鉢
HUP0001054A3 (en) 1997-08-06 2001-01-29 Daiichi Asubio Pharma Co Ltd 1-aryl-1,8-naphthyridin-4-one derivative as type iv phosphodiesterase inhibitor
CA2376760C (en) * 1999-07-01 2008-11-25 Wakunaga Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative or salts thereof
WO2001017991A1 (fr) * 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
JP2005097116A (ja) * 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
JP2005232000A (ja) * 2000-03-10 2005-09-02 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体又はその塩
CA2429440C (en) * 2000-11-20 2009-12-29 Daiichi Pharmaceutical Co., Ltd. Dehalogeno-compounds
CA2440412A1 (en) 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2004096221A1 (en) 2003-04-30 2004-11-11 Morphochem Aktiengesellschaft für kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
US8158797B2 (en) * 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
EP1709044B2 (en) 2003-12-18 2013-11-20 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US7576216B2 (en) 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
EP1789392A2 (en) * 2004-07-30 2007-05-30 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
US7622486B2 (en) * 2004-09-23 2009-11-24 Reddy Us Therapeutics, Inc. Pyridine compounds, process for their preparation and compositions containing them
WO2006042034A2 (en) 2004-10-08 2006-04-20 Abbott Laboratories Salt and crystalline forms thereof of a drug
DK1813610T3 (da) * 2004-11-17 2010-12-06 Wakunaga Pharma Co Ltd Nye pyridoncarboxylsyrederivater eller salte deraf
US20080287399A1 (en) * 2004-12-14 2008-11-20 Astrazeneca Ab Substituted Aminopyridines and Uses Thereof
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
PT1868581E (pt) * 2005-04-11 2012-06-22 Abbott Lab Composições farmacêuticas que possuem perfis de dissolução melhorados para fármacos pouco solúveis
US20090069360A1 (en) * 2006-03-16 2009-03-12 David Bryant Batt Organic Compounds
KR101450356B1 (ko) 2006-11-24 2014-10-15 에이씨 이뮨 에스.에이. 알츠하이머와 같은 아밀로이드 또는 아밀로이드-유사 단백질과 관련된 질환의 치료를 위한 ｎ-(메틸)-1ｈ-피라졸-3-아민, ｎ-(메틸)-피리딘-2-아민 및 ｎ-(메틸)-티아졸-2-아민 유도체
US7902227B2 (en) 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
EP2346855B1 (en) 2008-09-24 2017-04-05 Melinta Therapeutics, Inc. Process for making quinolone compounds
MY194407A (en) 2008-11-15 2022-11-30 Melinta Subsidiary Corp Antimicrobial Compositions
DE102009021535B8 (de) 2009-05-15 2012-12-13 Stabilo International Gmbh Verschlusskappe
EP2311823A1 (en) 2009-10-15 2011-04-20 AC Immune S.A. 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
KR20120101722A (ko) * 2009-12-25 2012-09-14 우베 고산 가부시키가이샤 아미노피리딘 화합물
CN103936717B (zh) * 2013-01-22 2016-08-10 上海医药工业研究院 一种delafloxacin中间体及其制备方法
CN103936718B (zh) * 2013-01-22 2016-06-29 上海医药工业研究院 一种高纯度delafloxacin的制备方法
EP2969004A4 (en) 2013-03-15 2016-09-21 Melinta Therapeutics Inc METHOD FOR THE TREATMENT OF INFECTIONS IN OVERWEIGHT AND ADIPOSIVE PATIENTS USING ANTIBIOTICS
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
TW201609652A (zh) * 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程（三）
CN104876911A (zh) * 2014-02-27 2015-09-02 南京工业大学 一种简易的方法合成德拉沙星
TWI705814B (zh) 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EA201791051A1 (ru) 2014-11-14 2018-01-31 Мелинта Терапьютикс, Инк. Способ лечения, профилактики или снижения риска возникновения кожной инфекции
UY37128A (es) * 2016-02-19 2017-09-29 Novartis Ag Compuestos tetracíclicos de piridona como antivirales
CN108033948A (zh) * 2017-12-28 2018-05-15 北京沃邦医药科技有限公司 一种德拉沙星及其中间体的制备
CN108084161A (zh) * 2017-12-28 2018-05-29 北京沃邦医药科技有限公司 德拉沙星及其中间体的制备方法
CN114507230B (zh) * 2020-11-17 2023-07-21 西华大学 一种双环吡啶酮类衍生物、其合成方法及其用途
CN114539213A (zh) * 2021-08-18 2022-05-27 广东工业大学 一种氟喹诺酮类化合物及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776917A (en) * 1972-06-05 1973-12-04 Schering Corp 2-amino-6-phenalkyl-aminopyridines and derivatives thereof
US3849429A (en) * 1973-03-30 1974-11-19 Olin Corp Halogenation of diaminopyridines in acidic media
US4994599A (en) * 1987-11-20 1991-02-19 Abbott Laboratories Intermediates for producing quinolone-3-carboxylic acids
JPS61152682A (ja) * 1984-12-27 1986-07-11 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体、そのエステルおよびその塩
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
JPH03112919A (ja) * 1989-09-26 1991-05-14 Kao Corp 角質繊維染色剤組成物
JPH03112966A (ja) * 1989-09-26 1991-05-14 Koei Chem Co Ltd ３―アルキル―２，６―ジアミノピリジンの製造法
JP2993316B2 (ja) * 1992-05-27 1999-12-20 宇部興産株式会社 アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JP2758722B2 (ja) * 1993-08-13 1998-05-28 ドング ホワ ファーマシューチカル インダストリアル カンパニー，リミテッド 新規キノロンカルボン酸誘導体
DE4425659A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren
DE4425647A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Heterocyclyl-1-phenyl substituierte Chinoloncarbonsäuren
KR100242355B1 (ko) * 1994-08-02 2000-03-02 데이비드 엠 모이어 항미생물 화합물의 제조 방법
JPH0848252A (ja) * 1994-08-04 1996-02-20 Otec Japan:Kk 荷 車
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
CA2211681C (en) * 1995-01-30 2003-05-13 Wakunaga Seiyaku Kabushiki Kaisha Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
NL1000360C2 (nl) * 1995-05-15 1996-11-18 Akzo Nobel Nv Werkwijze ter bereiding van pyridine-2, 6-diamines

Also Published As

Publication number Publication date
EP0911327B1 (en) 2001-12-05
US5998436A (en) 1999-12-07
RU2171252C2 (ru) 2001-07-27
BR9610485A (pt) 1999-07-27
BR9612862B8 (pt) 2014-08-05
CN1105715C (zh) 2003-04-16
JP3187795B2 (ja) 2001-07-11
KR100343331B1 (ko) 2002-07-15
US6133284A (en) 2000-10-17
HUP9904389A3 (en) 2002-03-28
EP0952151A3 (en) 2001-08-01
CA2232728A1 (en) 1997-03-27
DE69623358T2 (de) 2003-05-08
DK0992501T3 (da) 2002-10-28
DE69617750T2 (de) 2002-08-08
HU225224B1 (en) 2006-08-28
ES2169811T3 (es) 2002-07-16
JP3304311B2 (ja) 2002-07-22
DE69623358D1 (de) 2002-10-02
EP0952151B1 (en) 2003-05-28
DE69628466D1 (de) 2003-07-03
ES2200439T3 (es) 2004-03-01
HK1028032A1 (en) 2001-02-02
BR9610485B1 (pt) 2010-08-10
RU2000113595A (ru) 2004-02-20
ES2183473T3 (es) 2003-03-16
ATE241601T1 (de) 2003-06-15
KR100299430B1 (ko) 2001-09-06
ATE210129T1 (de) 2001-12-15
RU2167873C2 (ru) 2001-05-27
MX9802192A (es) 1998-09-30
EP0992501B1 (en) 2002-08-28
EP0992501A2 (en) 2000-04-12
HUP9904390A3 (en) 2002-03-28
RU2177945C1 (ru) 2002-01-10
HUP9902714A2 (hu) 1999-12-28
DK0952151T3 (da) 2003-09-22
EP0911327A4 (pt) 1999-04-28
EP0911327A1 (en) 1999-04-28
AU721805B2 (en) 2000-07-13
AU7001696A (en) 1997-04-09
CA2290709C (en) 2003-11-04
CA2290709A1 (en) 1997-03-27
DE69628466T2 (de) 2004-04-01
AU707565B2 (en) 1999-07-15
CA2232728C (en) 2003-11-04
PT952151E (pt) 2003-10-31
KR19990063671A (ko) 1999-07-26
CN1201459A (zh) 1998-12-09
HU9904390D0 (en) 2000-01-28
JP2000136191A (ja) 2000-05-16
CN1258674A (zh) 2000-07-05
EP0992501A3 (en) 2001-09-05
ATE222906T1 (de) 2002-09-15
HUP9902714A3 (en) 2002-03-28
EP0952151A2 (en) 1999-10-27
HK1016602A1 (en) 1999-11-05
CA2290712A1 (en) 1997-03-27
CA2290712C (en) 2003-09-09
JPH11322715A (ja) 1999-11-24
BR9610485B8 (pt) 2014-08-05
DE69617750D1 (de) 2002-01-17
DK0911327T3 (da) 2002-04-02
US6156903A (en) 2000-12-05
CN1258672A (zh) 2000-07-05
CN1136216C (zh) 2004-01-28
HU9904389D0 (en) 2000-01-28
WO1997011068A1 (fr) 1997-03-27
HU225225B1 (en) 2006-08-28
CN1196683C (zh) 2005-04-13
JP3103380B2 (ja) 2000-10-30
PT911327E (pt) 2002-05-31
AU3122799A (en) 1999-08-12

Similar Documents

Publication Publication Date Title
PT992501E (pt) Derivados de acido piridonacarboxilico como agentes antibacterianos
PA8510101A1 (es) Agentes antibacterianos de 3-aminoquinazolin-2,4 dionas.
BR9510006A (pt) Derivados de anilina possuindo efeito inibidor de sintase do óxido nítrico
MY121275A (en) 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
BR9914998A (pt) Antibióticos macrólidos
ATE357230T1 (de) Neue prodrugs für antimicrobielle amidine
DE69328366D1 (de) Benzopyran und benzoxazin-derivate
ATE178056T1 (de) Substituierte tertiäre amine und deren salze
PE71799A1 (es) Derivados de benzoxazindiona, aplicacion de los mismos y medicamentos que los contienen
CA2211681A1 (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
DE60111768D1 (de) N-formyl hydroxylamine derivate als inhibitoren der bakteriellen polypeptid deformylase zur behandlung von mikrobiellen infektionen
DE50001988D1 (de) DOLLAR g(a)- DOLLAR g(a)' -SUBSTITUIERTE N-ALKYL-3-ALKENYLBENZOYL-PYRAZOL-DERIVATE
BR0015156A (pt) Pró-drogas de higromicina a
JO1621B1 (en) Therapeutic agents
PT1144417E (pt) 4', 5'-di-hidropsolarenos substituidos na posicao 4' e suas utilizacoes terapeuticas
IT1162465B (it) Procedimento per proteggere materiali cheratinici da insetti ed agenti nonche' composti barbiturici per esso